157 related articles for article (PubMed ID: 12867065)
1. The importance of the eicosanoid pathway in lung cancer.
Laskin JJ; Sandler AB
Lung Cancer; 2003 Aug; 41 Suppl 1():S73-9. PubMed ID: 12867065
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.
Umar A; Steele VE; Menter DG; Hawk ET
Semin Oncol; 2016 Feb; 43(1):65-77. PubMed ID: 26970125
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
4. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.
Clish CB; Sun YP; Serhan CN
Biochem Biophys Res Commun; 2001 Nov; 288(4):868-74. PubMed ID: 11688989
[TBL] [Abstract][Full Text] [Related]
5. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
Sharma S; Sharma SC
Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
[TBL] [Abstract][Full Text] [Related]
6. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
7. Other compounds and targets in non-small cell lung cancer.
Villaflor V; Bonomi P
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S30-6. PubMed ID: 16459177
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
Grimes KR; Warren GW; Fang F; Xu Y; St Clair WH
Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492
[TBL] [Abstract][Full Text] [Related]
10. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
11. Eicosanoids: role in gastrointestinal inflammation and cancer.
Davies GR; Rampton DS
Eur J Gastroenterol Hepatol; 1997 Nov; 9(11):1033-44. PubMed ID: 9431891
[TBL] [Abstract][Full Text] [Related]
12. The effects of ibuprofen on eicosanoid synthesis in sepsis.
Fletcher JR
Crit Care Med; 1999 Apr; 27(4):669-70. PubMed ID: 10321641
[No Abstract] [Full Text] [Related]
13. Are selective COX 2 inhibitors superior to traditional NSAIDs? Little is known about COX 2 inhibitors.
Mamdani M; Juurlink DN; Anderson GM
BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12134854
[No Abstract] [Full Text] [Related]
14. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
16. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
Bozza PT; Payne JL; Morham SG; Langenbach R; Smithies O; Weller PF
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11091-6. PubMed ID: 8855314
[TBL] [Abstract][Full Text] [Related]
18. New NSAIDs-NO hybrid molecules with antiproliferative properties on human prostatic cancer cell lines.
Bézière N; Goossens L; Pommery J; Vezin H; Touati N; Hénichart JP; Pommery N
Bioorg Med Chem Lett; 2008 Aug; 18(16):4655-7. PubMed ID: 18667313
[TBL] [Abstract][Full Text] [Related]
19. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Suppl 2():S109-12. PubMed ID: 15899634
[TBL] [Abstract][Full Text] [Related]
20. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.
Hida T; Leyton J; Makheja AN; Ben-Av P; Hla T; Martinez A; Mulshine J; Malkani S; Chung P; Moody TW
Anticancer Res; 1998; 18(2A):775-82. PubMed ID: 9615719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
